5 trends tracked about this subject — the full history, oldest to newest below.
Arrowhead Pharmaceuticals shares surge following positive Phase 3 clinical trial results for its triglyceride lowering drug, plozasiran.
Arrowhead stock surges to multi-year highs following a major Phase 3 trial success, while chief rival Ionis falls.
AstraZeneca shares dropped six percent following a heart drug trial setback that simultaneously boosted rival stocks.
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.